Delivery Order SPE2DB20D1109-SPE2DB25FP26B
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Doxycycline 25 mg/5 mL suspension in 60 mL quantities, with a firm fixed price ceiling value of $2,730.00. This competitive award, which is not set-aside, represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Doxycycline 25 mg/5 mL suspension in a 60 mL quantity, with a ceiling value of $1,537.80. The contract employs firm fixed pricing with no set-aside designation, indicating the award resulted from open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Doxycycline 25 mg/5 mL suspension in a 60 mL quantity, with a ceiling value of $1,017.72. This contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 4, 2025. The award utilized no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp will perform from its corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Doxycycline 25 mg/5 ml suspension in 60 ml quantities under a firm fixed-price contract valued at $1,829.98. The award, issued on September 24, 2025, with an ultimate completion date of September 25, 2025, represents a non-competitive delivery order. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Doxycycline Hyclate, an antibiotic medication. This firm fixed-price delivery order, valued at $4,243.50, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999.999 billion and extends through December 2026. The delivery order carries no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 6, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units, valued at $2,151.96. This is a firm fixed price delivery order with an ultimate completion date of June 9, 2025, and represents a non-competitive set-aside contract. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 9, 2025, for the supply of Doxycycline Hydrochloride 200 mg tablets in a 60-count package. This firm fixed-price delivery order, valued at $9,367.44, is scheduled for completion by July 10, 2025, and represents a non-set-aside competitive award. The product will be supplied from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Doxycycline IR-DR 40 mg capsules (30-count) with a contract value of $3,077.22. This is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and no set-aside designation was utilized. The order will be performed in Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Doxycycline Hyclate 20 mg tablets (90-count packaging) with a ceiling value of $1,579.94. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The contract carries an ultimate completion date...
- The Defense Logistics Agency awarded a delivery order valued at $2,902.88 to AmerisourceBergen Drug Corp for the supply of Doxycycline 25 mg/5 ml Suspension in 60 ml quantities. This competitive award, which was not set-aside, was issued on August 6, 2025, with an ultimate completion date of August 7, 2025, and carries firm fixed price terms. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP26BDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Doxycycline 25 mg/5 mL suspension in 60 mL quantities, with a ceiling value of $3,238.08. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and is scheduled for completion by June 20, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to military and veteran healthcare systems. The IDC serves as a global pharmaceutical support vehicle enabling the company to fulfill diverse medical commodity requirements, including antibiotics such as this doxycycline order, across multiple therapeutic domains for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 6/18/25 |